Publications

5543 Results

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency

Authors
S Stecklein;W Barlow;L Pusztai;K Timms;R Kennedy;G Logan;R Seitz;S Badve;Y Gokmen-Polar;P Porter;H Linden;D Tripathy;G Hortobagyi;A Godwin;A Godwin;A Thompson;D Hayes;P Sharma
Journal / Conference
JCO Precision Oncology Sep:7:e2300197. doi: 10.1200/PO.23.00197
Year
2023
Research Committee(s)
Breast
PMID
PMID37972336
PMC
PMC10681491
Study Number(s)
SWOG-9313

Mixed-methods analysis of physician genomic confidence in the pre-implementation phase of the cluster randomized trial evaluating genomic tumor boards (SWOG S2108CD, NCT05455606)

Authors
M Trivedi;J Rueter;J Unger;K Arnold;S Colby;A Michel;A Taboada;L Graham;K Reed;J Fischer;B Symington;S Ramsey;D Hershman
Journal / Conference
ASCO Quality Care Symposium (October 27-28, 2023, Boston, MA, poster; JCO Oncol Pract 19, 2023 (suppl 11; abstr 439)
Year
2023
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S2108CD

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients

Authors
E Pogosova-Agadjanyan;X Hua;M Othus;F Appelbaum;T Chauncey;H Erba;M Fitzgibbon;J Godwin;I Jenkins;M Fang;A Moseley;J Naru;J Radich;B Willborg;C Willman;F Wu;S Meshichi;D Stirewalt
Journal / Conference
Biomarker Research Mar 16;11(1):31. doi: 10.1186/s40364-023-00461-0
Year
2023
Research Committee(s)
Leukemia
PMID
PMID36927800
PMC
PMC10022072
Study Number(s)
S0106, S0112, SWOG-9031, SWOG-9333

Clinical trial design change implementation for inclusive studies

Authors
M Espinoza Gutarra;J Aiello;R Orlowski;S Ailawadhi
Journal / Conference
Lancet Hematology Dec;10(12):e953-e954. doi: 10.1016/S2352-3026(23)00336-8
Year
2023
Research Committee(s)
Myeloma
PMID
PMID38030317
Study Number(s)
S2209

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221

Authors
C Chen;G Zirpoli;S McCann;W Barlow;GT Budd;L Pusztai;NL Henry;A Godwin;A Thompson;C Ambrosone;K Stringer;D Hertz
Journal / Conference
Journal of the National Comprehensive Cancer Network Nov;21(11):1172-1180.e3
Year
2023
Research Committee(s)
Breast
PMID
PMID37935109
PMC
PMC10976748
Study Number(s)
S0221

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.

Authors
L Dillon;J Higgins;H Nasif;M Othus;L Beppu;T Smith;E Schmidt;C Valentine;J Salk;B Wood;J Radich;C Hourigan
Journal / Conference
Haematologica Aug 3; doi: 10.3324/haematol.2023.283520 Online ahead of print
Year
2023
Research Committee(s)
Leukemia
PMID
PMID:37534515
PMC
PMC10081409
Study Number(s)
S0106

Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing

Authors
DL Hershman;A Bansal;W Barlow;K Arnold;K Watabayashi;A Bell-Brown;S Sullivan;G Lyman;S Ramsey
Journal / Conference
JCO Oncology Practice Dec;19(12):1160-1167
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37788414
PMC
PMC10732502
Study Number(s)
S1415CD

Impact of Treatment Experience on Patient Knowledge of Colony Stimulating Factors Among Patients Receiving Cancer Chemotherapy: Evidence from S1415CD, A Large Pragmatic Trial

Authors
G Lyman;A Bansal;S Sullivan;K Arnold;W Barlow;D Hershman;T Lad;S Ramsey
Journal / Conference
Supportive Care in Cancer Sep 28;31(10):598
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37770704
PMC
PMC11060514
Study Number(s)
S1415CD

Sociodemographic risk factors and prediction of aromatase inhibitor non-adherence in women with breast cancer enrolled in SWOG S1105

Authors
DL Hershman;A Moseley;K Arnold;J Gralow;A Neugut;S Ramsey;NL Henry;J Unger
Journal / Conference
SABCS (San Antonio Breast Cancer Symposium, December 5-9, San Antonio, TX), Poster Spotlight Discussion, PS04-08
Year
2023
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1105

Long-term Follow for SWOG 1318: Combination of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)

Authors
A Advani;A Moseley;K O'Dwyer;B Wood;J Park;M Wieduwilt;D Jeyakumar;G Yaghmour;E Atallah;A Gerds;S O'Brien;J Liesveld;M Othus;M Litzow;R Stone;E Sharon;C Yeung;J Radich;H Erba
Journal / Conference
ASH Annual Meeting (Dec9-12,2023, San Diego, CA), poster
Year
2023
Research Committee(s)
Leukemia
Study Number(s)
S1318